Equity Analysis

Quarterly Results

    Astrazeneca Pharma India Ltd
    Industry :  Pharmaceuticals - Multinational
    BSE Code
    ISIN Demat
    Book Value()
    506820
    INE203A01020
    271.74
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    ASTRAZEN
    138.16
    17784.38
    EPS(TTM)
    Face Value()
    Div & Yield %:
    51.49
    2
    0.34
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales408.00387.52383.20
Other Operating Income0.000.000.00
Other Income 8.158.358.66
Total Income416.15395.87391.86
Total Expenditure 355.46407.01333.81
PBIDT60.69-11.1458.05
Interest 0.340.11-0.07
PBDT60.35-11.2558.12
Depreciation9.323.913.76
Tax14.7010.7515.52
Fringe Benefit Tax0.000.000.00
Deferred Tax-2.10-14.12-0.64
Reported Profit After Tax38.43-11.7939.48
Extra-ordinary Items 0.00-46.810.00
Adjusted Profit After Extra-ordinary item38.4335.0239.48
EPS (Unit Curr.)16.37-4.7215.79
EPS (Adj) (Unit Curr.)16.37-4.7215.79
Calculated EPS (Unit Curr.)15.37-4.7215.79
Calculated EPS (Adj) (Unit Curr.)15.37-4.7215.79
Calculated EPS (Ann.) (Unit Curr.)61.49-18.8663.17
Calculated EPS (Adj) (Ann.) (Unit Curr.)61.49-18.8663.17
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity5.005.005.00
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)14.88-2.8715.15
PBDTM(%)14.79-2.9015.17
PATM(%)9.42-3.0410.30
Dividend Per Share(Rs)0.000.000.00
Diluted EPS16.37-4.7215.79